Athersys has established a synergistic set of capabilities that include novel, proprietary technologies that enable the company to efficiently develop a diverse set of high value therapeutic product opportunities. These capabilities include a diverse compound library, proprietary genomics tools and technologies, and a distinctive adult stem cell platform. Through the integration of these capabilities, the company has developed multiple product types - including synthetic pharmaceuticals, and cell therapy products - that encompass a range of disease areas.